The proprietary firm was converted to a Private Limited Company in 1980, and Mr. Bhupatinath Mitra was appointed as Chairman and
Mrs. Annapurna Mitra was appointed as Managing Director of the Company.   In 1982 Professor Mitra, who has been rendering part-time consultancy services to the Company, joined C MARC as a full-timer and took up the reins as Managing Director while Mrs. Mitra became the Joint MD.

Glaxo became the pioneer as the exclusive user of C MARC, launched Continuous Prescription Research (CPR) Service.

DIFFERENTIATED   STANDING   OF   C MARC

• Pioneer in Prescription Research study  :  Continuous Rx Research (Referred as ‘CPR’) 

• Outstanding authority ensuring creativity in research for strategic Healthcare Management decision making in 

• Corporate Management
• Marketing Management

• Innovativeness in perspective setting covering
  
  
  • Short Term
  • Medium Term
  • Long Term

business strategy for the client organization.

• C MARC is recognized by globetrotting transnational and national companies for
  
  
• Dependable Strategic Marketing Consultancy Services indicating steps for specific implementation covering
  
  
• Product Management
• Field Management

                                               
across the different Sectors and Segments of Specialization.